Typicality: | 0.347 |
Saliency: | 0.432 |
against the parasites | 6 | transitive-object |
in preclinical studies | 5 | location |
in treating cancer cells | 5 | other |
compound → be → successful | 26 |
negative | neutral | positive |
0.072 | 0.312 | 0.616 |
Raw frequency | 26 |
Normalized frequency | 0.432 |
Modifier score | 0.500 |
Perplexity | 335.148 |